NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
企業コードNMTC
会社名NeuroOne Medical Technologies Corp
上場日Nov 09, 2012
最高経営責任者「CEO」Mr. David A. (Dave) Rosa
従業員数17
証券種類Ordinary Share
決算期末Nov 09
本社所在地7599 Anagram Dr
都市EDEN PRAIRIE
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号55344-7399
電話番号19524261383
ウェブサイトhttps://nmtc1.com/
企業コードNMTC
上場日Nov 09, 2012
最高経営責任者「CEO」Mr. David A. (Dave) Rosa
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし